Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR)

Overview of attention for article published in British Medical Journal, October 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 7 news outlets
blogs: 3 blogs
twitter: 303 X users
facebook: 4 Facebook pages
wikipedia: 1 Wikipedia page

googleplus: 3 Google+ users
reddit: 2 Redditors
video: 1 YouTube creator
guideline: 1 clinical guideline source

Readers on

mendeley: 208 Mendeley

So far, Altmetric has seen 9 news stories from 7 outlets.

New Findings on Polypharmacy in Depression

Medical Health News, 11 Mar 2019

This transcript has been edited for clarity. This is the Medscape Psychiatry Minute.

Dépression résistante : une association d’antidépresseurs ne fait pas mieux qu’un seul

Pourquoi Docteur , 05 Nov 2018

Les psychiatres associent de plus en plus la mirtazapine à un ISRS (inhibiteur sélectif du recaptage de la sérotonine) ou à un…

GPs should stop co-prescribing mirtazapine and SSRIs for depression, says study

Medical Health News, 03 Nov 2018

Prescribing mirtazapine with SSRIs or SNRIs for treatment-resistant depression is no more effective than placebo, a study has…

Drug combination not more effective in improving depression than single antidepressant

The Medical News, 01 Nov 2018

Psychiatrists and GPs increasingly combine mirtazapine with an SSRI (selective serotonin reuptake inhibitor) or SNRI (serotonin-n…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 5 additional news stories.